ATRA vs JNJ: Which Stock is Better?
Side-by-side comparison of Atara Biotherapeutics Inc and Johnson & Johnson in 2026
ATRA
Atara Biotherapeutics Inc
$4.32
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | ATRA | JNJ | Winner |
|---|---|---|---|
| Market Cap | $32.73M | $525.73B | JNJ |
| P/E Ratio | 1.59 | 21.10 | ATRA |
| EPS (TTM) | $2.86 | $10.34 | JNJ |
| Revenue Growth | -0.9% | 0.1% | JNJ |
| Gross Margin | 46.8% | 68.4% | JNJ |
Analyze ATRA
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ATRA or JNJ a better investment?
Comparing ATRA and JNJ: Atara Biotherapeutics Inc has a market cap of $32.73M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ATRA and JNJ?
ATRA (Atara Biotherapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ATRA or JNJ?
Based on P/E ratios, ATRA trades at a lower multiple (1.6x vs 21.1x).
Which is growing faster: ATRA or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.9% for ATRA.
Which company is more profitable: ATRA or JNJ?
Johnson & Johnson (JNJ) has higher gross margins at 68.4% compared to 46.8% for ATRA.
Which is the larger company: ATRA or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $32.73M for ATRA.
Should I buy ATRA or JNJ in 2026?
Both ATRA and JNJ have investment merit. ATRA trades at $4.32 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ATRA and JNJ stock?
Key differences: Market Cap ($32.73M vs $525.73B), P/E Ratio (1.6x vs 21.1x), Revenue Growth (-0.9% vs 0.1%), Gross Margin (46.8% vs 68.4%).